1. Presentation of the combined management report regarding the consolidated financial statements and the annual accounts of the Company for the financial year ended 31 December 2025
Keine Abstimmung erforderlich
2. Presentation of the reports of the independent auditor (réviseur d'entreprises agréé) of the Company on the consolidated financial statements for the financial year ended 31 December 2025 and on the Company's annual accounts for the financial year ended 31 December 2025.
Keine Abstimmung erforderlich
3. Approval of the Company's annual accounts for the financial year ended 31 December 2025.
4. Acknowledgement of the result of the Company made for the financial year ended 31 December 2025 and allocation of the results of the Company for the financial year ended 31 December 2025.
5. Approval of the Company's consolidated financial statements for the financial year ended 31 December 2025.
6. Presentation of and advisory vote on the remuneration policy for the members of the Management Board and the Supervisory Board of the Company applicable as from the financial year 2026.
7. Presentation of and advisory vote on the remuneration report for the members of the Management Board and the Supervisory Board of the Company in the financial year ended 31 December 2025.
8. Granting of discharge (quitus) to Christoph Schuh, member of the Supervisory Board, for the exercise of his mandate during the financial year ended on 31 December 2025.
9. Granting of discharge (quitus) to Dr. Dirk Altenbeck, member of the Supervisory Board, for the exercise of his mandate during the financial year ended on 31 December 2025.
10. Granting of discharge (quitus) to Dr. Florian Heinemann, member of the Supervisory Board, for the exercise of his mandate during the financial year ended on 31 December 2025.
11. Granting of discharge (quitus) to Philipp Kloeckner, member of the Supervisory Board, for the exercise of his mandate during the financial year ended on 31 December 2025.
12. Granting of discharge (quitus) to Susanne Sandler, member of the Supervisory Board, for the exercise of her mandate during the financial year ended on 31 December 2025.
13. Granting of discharge (quitus) to Florian Schuhbauer, member of the Supervisory Board, for the exercise of his mandate during the financial year ended on 31 December 2025.
14. Granting of discharge (quitus) to Christina Smedley, member of the Supervisory Board, for the exercise of her mandate during the financial year ended on 31 December 2025.
15. Granting of discharge (quitus) to Dr. Patrick Andrae, member of the Management Board, for the exercise of his mandate during the financial year ended on 31 December 2025.
16. Granting of discharge (quitus) to Wolfgang Heigl, member of the Management Board, for the exercise of his mandate during the financial year ended on 31 December 2025.
17. Granting of discharge (quitus) to Valentin Gruber, member of the Management Board, for the exercise of his mandate during the financial year ended on 31 December 2025.
18. Granting of discharge (quitus) to Sebastian Bielski, member of the Management Board, for the exercise of his mandate during the financial year ended on 31 December 2025.
19. Granting of discharge (quitus) to Steffen Schneider, member of the Management Board, for the exercise of his mandate during the financial year ended on 31 December 2025.
20. Renewal of the mandate of Ernst & Young Luxembourg, a société anonyme, having its registered office at 35E, Avenue John F. Kennedy, L-1855 Luxembourg, Grand Duchy of Luxembourg, registered with the Luxembourg Trade and Companies Register under number B88019, as independent auditor (réviseur d'entreprises agréé) of the Company for a period ending at the general meeting of shareholders of the Company approving the annual accounts relating to the financial year ending on 31 December 2026.
Hinweis: Auf der Hauptversammlung kann aus sachlichen Gründen gemäß den gesetzlichen Bestimmungen von oben genanntem Abstimmungsverhalten abgewichen werden.
Keine Abstimmung erforderlich